BioNexus Gene Lab (BGLC) Return on Capital Employed (2019 - 2026)
BioNexus Gene Lab recorded quarterly Return on Capital Employed of 34.58% in Q1 2026, up 7.69% quarter-over-quarter from 37.46% in Q4 2025, and down 941.0% year-over-year from 4.11% in Q1 2025.
BioNexus Gene Lab's Return on Capital Employed history runs 8 years deep, the most recent figure standing at 34.58% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 941.0% year-over-year to 34.58%; the TTM figure through Mar 2026 stood at 34.58% (down 941.0% YoY), while the FY2025 annual figure was 31.81%, down 1425.0% from the prior year.
- Return on Capital Employed came in at 34.58% for Q1 2026 at BioNexus Gene Lab, up from 37.46% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 10.13% in Q1 2022 to a low of 38.78% in Q2 2025.
- A 5-year average of 18.05% and a median of 21.44% in 2024 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed tumbled 3748 bps in 2023 and jumped 2768 bps in 2024, its largest moves.
- BioNexus Gene Lab's Return on Capital Employed stood at 4.65% in 2022, then sank by 469 bps to 26.46% in 2023, then jumped by 32 bps to 17.96% in 2024, then plunged by 109 bps to 37.46% in 2025, then advanced by 8 bps to 34.58% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 34.58%, 37.46%, and 29.94% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn | 12.89% |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn | - |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn | 20.78% |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn | 14.59% |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn | 6.05% |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn | 13.59% |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn | -1.10% |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn | 6.09% |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn | 7.03% |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 | -34.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.58% |
| Dec 31, 2025 | -37.46% |
| Sep 30, 2025 | -29.94% |
| Jun 30, 2025 | -38.78% |
| Mar 31, 2025 | -25.17% |
| Dec 31, 2024 | -17.96% |
| Sep 30, 2024 | -9.32% |
| Jun 30, 2024 | -21.44% |
| Mar 31, 2024 | -27.41% |
| Dec 31, 2023 | -26.46% |
| Sep 30, 2023 | -37.00% |
| Jun 30, 2023 | -8.28% |
| Mar 31, 2023 | -5.46% |
| Dec 31, 2022 | -4.65% |
| Sep 30, 2022 | 0.48% |
| Jun 30, 2022 | 6.47% |
| Mar 31, 2022 | 10.13% |
| Dec 31, 2021 | 14.38% |
| Sep 30, 2021 | 12.27% |
| Jun 30, 2021 | 10.09% |
| Mar 31, 2021 | 7.78% |
| Dec 31, 2020 | 58.15% |
| Sep 30, 2020 | 118.24% |
| Jun 30, 2020 | 85.31% |
| Mar 31, 2020 | 75.82% |
| Dec 31, 2019 | -22.30% |
| Mar 31, 2019 | -9.89% |